RNF43 mutations, commonly detected in CRC (Giannakis et al., 2014), enhance the sensitivity of tumor cells toward the porcupine inhibitor IWP2 (van de Wetering et al., 2015). Here, RNF43 is linked to colorectal carcinoma.